A New Weak Spot in Prostate Cancer: Disarming the Androgen Signal by Targeting PTGES3

November 7, 2025/in CRISPR, Preclinical Research/by Max

A new study shows, published on Nature, that a little-known protein called PTGES3 helps prostate cancer cells keep using male hormone signals to grow, even when treatments are trying to shut those signals down. Blocking this helper protein cut off the cancer’s fuel supply in lab tests and slowed tumors in mice, pointing to a […]